177 related articles for article (PubMed ID: 24689343)
1. Commentary: tenofovir is superior to entecavir in HBeAg-positive chronic hepatitis B patients.
Bradshaw D; Danta M
Aliment Pharmacol Ther; 2014 May; 39(9):992. PubMed ID: 24689343
[No Abstract] [Full Text] [Related]
2. Commentary: tenofovir is superior to entecavir in HBeAg-positive chronic hepatitis B patients--authors' reply.
Gao L; Trinh HN; Li J; Nguyen MH
Aliment Pharmacol Ther; 2014 May; 39(9):993. PubMed ID: 24689344
[No Abstract] [Full Text] [Related]
3. Letter: Treatment of HBeAg+ chronic hepatitis B--is tenofovir truly superior to entecavir?
Sadler MD; Lee SS
Aliment Pharmacol Ther; 2014 Jun; 39(11):1339. PubMed ID: 24803253
[No Abstract] [Full Text] [Related]
4. Letter: Treatment of HBeAg+ chronic hepatitis B--is tenofovir truly superior to entecavir? Authors' reply.
Gao L; Trinh HN; Li J; Nguyen MH
Aliment Pharmacol Ther; 2014 Jun; 39(11):1339-40. PubMed ID: 24803254
[No Abstract] [Full Text] [Related]
5. Tenofovir and entecavir are the most effective antiviral agents for chronic hepatitis B: a systematic review and Bayesian meta-analyses.
Woo G; Tomlinson G; Nishikawa Y; Kowgier M; Sherman M; Wong DK; Pham B; Ungar WJ; Einarson TR; Heathcote EJ; Krahn M
Gastroenterology; 2010 Oct; 139(4):1218-29. PubMed ID: 20600036
[TBL] [Abstract][Full Text] [Related]
6. Letter: First-line monotherapies for chronic hepatitis B - indirect comparison between entecavir and tenofovir.
Maratea D; Fadda V; Trippoli S; Messori A
Aliment Pharmacol Ther; 2013 Mar; 37(5):584-5. PubMed ID: 23369168
[No Abstract] [Full Text] [Related]
7. [Efficacy and treatment strategy for drug resistances of nucleos(t)ide analogues for chronic hepatitis B].
Hosaka T; Suzuki F; Kumada H
Nihon Shokakibyo Gakkai Zasshi; 2011 Feb; 108(2):210-4. PubMed ID: 21307624
[No Abstract] [Full Text] [Related]
8. Comparison of the efficacy of entecavir and tenofovir in chronic hepatitis B.
Güzelbulut F; Ovünç AO; Oetinkaya ZA; Senates E; Gökden Y; Saltürk AG; Sezikli M; Ozkara S; Cetinkaya F
Hepatogastroenterology; 2012; 59(114):477-80. PubMed ID: 21940383
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of entecavir with or without tenofovir disoproxil fumarate for nucleos(t)ide-naïve patients with chronic hepatitis B.
Lok AS; Trinh H; Carosi G; Akarca US; Gadano A; Habersetzer F; Sievert W; Wong D; Lovegren M; Cohen D; Llamoso C
Gastroenterology; 2012 Sep; 143(3):619-628.e1. PubMed ID: 22643350
[TBL] [Abstract][Full Text] [Related]
10. [Protocol for the antiviral therapy of chronic hepatitis B].
;
Orv Hetil; 2008 Dec; 149(49):2341-3. PubMed ID: 19042187
[No Abstract] [Full Text] [Related]
11. Entecavir plus tenofovir versus entecavir plus adefovir in chronic hepatitis B patients with a suboptimal response to lamivudine and adefovir combination therapy.
Park JG; Park SY
Clin Mol Hepatol; 2015 Sep; 21(3):242-8. PubMed ID: 26523269
[TBL] [Abstract][Full Text] [Related]
12. [Improvement of health-related quality of life in chronic hepatitis B patients treated with entecavir or adefovir].
Yu JH; Li Q; Yang X; Fan WB; Xie SS; Li WW; Liu L; Chen SJ
Zhonghua Gan Zang Bing Za Zhi; 2011 Apr; 19(4):305-6. PubMed ID: 21805739
[No Abstract] [Full Text] [Related]
13. Treatment of chronic hepatitis B in clinical practice with entecavir or tenofovir.
Ridruejo E
World J Gastroenterol; 2014 Jun; 20(23):7169-80. PubMed ID: 24966587
[TBL] [Abstract][Full Text] [Related]
14. Optimal therapy of chronic hepatitis B: how do I treat HBeAg-positive patients?
Vlachogiannakos J; Papatheodoridis GV
Liver Int; 2015 Jan; 35 Suppl 1():100-6. PubMed ID: 25529094
[TBL] [Abstract][Full Text] [Related]
15. New perspectives in the therapy of chronic hepatitis B.
Lampertico P; Liaw YF
Gut; 2012 May; 61 Suppl 1():i18-24. PubMed ID: 22504916
[No Abstract] [Full Text] [Related]
16. Incorporated antivirals for chronic hepatitis B in Brazil: a cost-effectiveness analysis.
Oliveira GL; Almeida AM; Silva AL; Brandão CM; Andrade EI; Cherchiglia ML; Acurcio Fde A
Rev Saude Publica; 2013 Aug; 47(4):769-78; discussion 779. PubMed ID: 24346678
[TBL] [Abstract][Full Text] [Related]
17. Canadian patients with chronic hepatitis B cannot access appropriate drug treatments: a call for change.
Sherman M; Lee SS
Can J Gastroenterol; 2011 Oct; 25(10):538-41. PubMed ID: 22059156
[No Abstract] [Full Text] [Related]
18. Optimal therapy of chronic hepatitis B: how do I treat my HBeAg-negative patients?
Viganò M; Invernizzi F; Lampertico P
Liver Int; 2015 Jan; 35 Suppl 1():107-13. PubMed ID: 25529095
[TBL] [Abstract][Full Text] [Related]
19. Mixed treatment comparison meta-analysis evaluating the relative efficacy of nucleos(t)ides for treatment of nucleos(t)ide-naive patients with chronic hepatitis B.
Dakin H; Fidler C; Harper C
Value Health; 2010 Dec; 13(8):934-45. PubMed ID: 20825624
[TBL] [Abstract][Full Text] [Related]
20. [Comparison of efficacy between adefovir dipivoxil and entecavir in patients with chronic hepatitis B].
Yang F; Wu XF; Wei N
Zhonghua Gan Zang Bing Za Zhi; 2010 Jan; 18(1):65-6. PubMed ID: 20128975
[No Abstract] [Full Text] [Related]
[Next] [New Search]